NCT06204107View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 21, 2023

Primary Completion Date

December 6, 2023

Study Completion Date

December 6, 2023

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

CKD-379(Empagliflozin+sitagliptin+metformin) Test drug

oral, once

DRUG

CKD-379(Empagliflozin+sitagliptin+metformin) Reference drug

oral, once

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seongnam

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY